|
Volumn 21, Issue 2, 2014, Pages 79-81
|
Comment on the new guidelines in USA by the JAS guidelines committee
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
FLUINDOSTATIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PITAVASTATIN;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
ACUTE CORONARY SYNDROME;
ACUTE HEART INFARCTION;
ATHEROSCLEROTIC CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL PRACTICE;
EDITORIAL;
HEALTH CARE POLICY;
HUMAN;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
ATHEROSCLEROSIS;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
|
EID: 84894632852
PISSN: 13403478
EISSN: 18803873
Source Type: Journal
DOI: 10.5551/jat.ED001 Document Type: Editorial |
Times cited : (14)
|
References (0)
|